“The lowered rating reflects BHSF’s significantly weaker operating performance and cash flow, with deficit operations through the three months ended Dec. 31, 2015, and with our expectation that operations will remain stressed in the near term,” said S&P credit analyst Stephen Infranco.
The outlook is stable, reflecting S&P’s view of BHSF’s strong management team, sound business position and expectation that management will be prudent in its capital spending over the two-year outlook period.
Moody’s also lowered its long-term rating to “AA-” from “AA” on BSHF’s series 2007 revenue bonds.
More articles on healthcare finance:
Hospitals praise CMS’ plan to drop two-midnight inpatient payment cuts
S&P assigns ‘A-‘ rating to CareGroup’s bonds
Fitch assigns ‘A+’ rating to CentraCare’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
